Form 4 for CSW CSW INDUSTRIALS, INC.
Accepted 2026-04-07 17:31:29 ET · period of report 2026-04-02 · accession 0001413614-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-04-07 17:31 | 2026-04-02 | CSW | Armes Joseph B | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +42.8K | 102.3K | +72% | $0 |
| D | 2026-04-07 17:31 | 2026-04-02 | CSW | Armes Joseph B | COB, Pres, CEO, Dir | F - Tax | $260.34 | -16.3K | 86.0K | -16% | -$4.24M |
| DM | 2026-04-07 17:31 | 2026-04-02 | CSW | Armes Joseph B | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -21.6K | 9,186 | -70% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-02 | M | A | 23,968 | $0.00 | 83,494 | D | — | — | (F1) Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 146 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. |
| 2 | Common | Common Stock | 2026-04-02 | M | A | 18,784 | $0.00 | 102,278 | D | — | — | (F2) Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of April 1, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,186 performance rights for the performance cycle ended April 1, 2026, along with 206 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. |
| 3 | Common | Common Stock | 2026-04-02 | F | D | 16,284 | $260.34 | 85,994 | D | — | — | |
| 4 | Derivative | Performance Rights | 2026-04-02 | M | D | 12,422 | $0.00 | 0 | D | — · — to — | 12,422 Common Stock | (F1) Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 146 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. (F1) Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 146 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. (F1) Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 146 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. |
| 5 | Derivative | Performance Rights | 2026-04-02 | M | D | 9,186 | $0.00 | 9,186 | D | — · — to — | 9,186 Common Stock | (F2) Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of April 1, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,186 performance rights for the performance cycle ended April 1, 2026, along with 206 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. (F2) Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of April 1, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,186 performance rights for the performance cycle ended April 1, 2026, along with 206 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. (F2) Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of April 1, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,186 performance rights for the performance cycle ended April 1, 2026, along with 206 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. |